Building on Our Foundation
As Fred Hutch approaches its 50th anniversary, the steps we have taken in recent years to reshape our organization and unite innovative research with compassionate care are allowing us to gain ground on our goal to prevent and eliminate cancer and infectious disease. From creating more space for discovery to adding new leaders to guide our clinical care, this year built on the foundation established in 1975 and refreshed in 2022 through our merger. This report highlights some of the specific accomplishments of the past year and illustrates our commitment to our patients, our people and our community.
Land Acknowledgment
Fred Hutch Cancer Center acknowledges the Coast Salish peoples of this land, the land which touches the shared waters of all tribes and bands within the Suquamish, Tulalip and Muckleshoot nations.
Fred Hutch President Dr. Thomas J. Lynch Jr., who holds the Raisbeck Endowed Chair, discusses leadership and the power of storytelling in a Heart of the Hutch interview with Senior Multimedia Producer Robert Hood as part of Fred Hutch Cancer Center's 2024 annual report.
Clinical Developments
The last two years have seen significant growth in Fred Hutch's patient population as well as changes across our clinical operations with new treatments and new people. We welcomed new leadership in our immunotherapy and nursing teams — and our providers continued to be recognized as the best in their fields and in the region.
Clinical Highlights and Stories
Dr. Mazyar Shadman, new medical director of the Bezos Family Immunotherapy Clinic, says services are expanding
Increasing timely access to immunotherapy is a main goal.
Fred Hutch's new chief nursing officer says tragedy altered her perspective
Denene Prophet-Williams has a passion for solving problems while supporting patient care.
New deputy CMO brings Texas-sized expertise
Dr. Nicole Fleming takes over daily operations of South Lake Union clinic that has grown by 30% in three years.
Fred Hutch clinicians recognized as Seattle Met Magazine’s 2024 Top Doctors
Over 80 physicians, physician assistants and nurse practitioners named in annual list.
Comprehensive Hematology and Oncology Review Course marks 15 years
Started as a personal project, oncology course now covers hematology, too.
20 Years Since a Key EGFR Discovery
Nearly 20 years ago, a Fred Hutch lung cancer patient was among the first people to benefit from a new class of drugs — a targeted therapy called EGFR inhibitors.
Patient Care by the Numbers
Data from our 2024 fiscal year ended June 30.
63K
360
11K
Scientific Developments
Our researchers advanced human understanding across a wide range of areas, reflecting the diversity of expertise at Fred Hutch that allows us to develop potential cures for cancer and infectious diseases. Our teams also applied artificial intelligence and other new approaches to match existing treatments to diagnoses or better understand how cancer may be impacting individuals in different ways.
Research Highlights and Stories
Dr. Lawrence Fong, new immunotherapy director, talks about how the field has transformed oncology
In-house grant funding program will underpin efforts to advance therapies to clinical trials.
More to brain tumors than meets the eye
Fred Hutch researchers find new way to classify tumors based on their underlying biology rather than how they look.
Mapping a pathway to hope
A team of Fred Hutch researchers revealed the biology behind a drug’s success in a rare liver cancer and paired it with another drug for a one-two punch.
Fred Hutch launches rare cancer research effort
New TRACER initiative aims to accelerate advances through multidisciplinary collaboration and innovative approaches.
Bacteria subtype linked to growth in up to 50% of human colorectal cancers, researchers report
A study published in Nature suggests that a subtype of Fusobacterium nucleatum underlies colorectal cancer growth in humans and could be useful in screening and treatments.
A quarter century of lifesaving discoveries in prostate cancer
Pacific Northwest Prostate Cancer SPORE insights have transformed patient care and understanding of prostate cancer biology, supported drug discovery worldwide.
Research by the Numbers
Data from our 2024 fiscal year ended June 30.
1,330
52
58
Philanthropic Highlights
In 2024, supporters from all 50 states rallied behind the pursuit of a shared vision: a healthier future for all. You and other members of our community drew on your motivation, imagination and inspiration to fuel discoveries, whether by scaling the Space Needle, exploring our cutting-edge laboratories, volunteering your time or entrusting us with gifts large and small. And, with a $15 million gift from Carl and Renée Behnke jump-starting our Anniversary Challenge, we’re preparing to enter our 50th year at a moment of stunning possibility in science and patient care. With your help, we’re already looking beyond what’s possible today toward the next world-changing discoveries.
Philanthropic Highlights and Stories
Obliteride community brings unstoppable energy in 2024
In August, more than 7,000 participants and volunteers brought their passion to the largest-ever Obliteride, Fred Hutch’s annual bike ride, walk/run and fundraiser.
Explore the 2024 Obliteride Annual Report.
Life after cancer: funding cures, feeding patients, finding purpose
For visual designer and lymphoma survivor Aaron Fields, Smith Brothers Farms’ Drink Pink program represents a full-circle moment to give back to Fred Hutch and help others affected by cancer.
New endowed chair is gaining invaluable insight through fundamental research
Developmental biologist Cecilia Moens, PhD, who now holds the Raisbeck Endowed Chair for Basic Science, studies embryonic development in zebrafish, giving insight into similar processes in humans.
Foundation award fuels study of cancer cell cooperation
Supported by a grant from the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation, Fred Hutch breast cancer researcher Kevin Cheung, MD, is exploring how cancer cells collaborate to survive, spread and grow.
Stream for Fred Hutch
A dozen content streamers came together for 1-UP for Cancer Survivors, a week-long online streaming event that raised $25,000 for Fred Hutch research from nearly 200 donors. In all, over 35 content creators supported us through their streaming fundraisers this year.
Taking action to honor a child, a friend and all those experiencing cancer
Financial Planner Renee Hawkes, who chairs our Professional Advisory Council, is making Fred Hutch part of her legacy — and helping others craft their own.
Philanthropy by the Numbers
A snapshot of support from July 1, 2023 to June 30, 2024.
40,025
94%
1,300
6,911
Every Dollar Counts
Support lifesaving discoveries today.
Diversity, Equity & Inclusion
Fred Hutch remains steadfast and clear about our commitments and strategy for diversity, equity and inclusion, reflecting our values and recognizing the urgency of our mission. We continue to share the progress we’ve made, challenges/opportunities to take our work further, and lessons we have learned.
2024 DEI Annual Progress Report
Our fourth annual Diversity, Equity & Inclusion Progress Report describes our persistence and shares some highlights of our demonstrated work in four key areas: health equity, employee engagement and workforce data, Pathways to Science, and the complementary activities of the DEI Core department and the Office of Faculty Affairs and Diversity. As you read about our work, we encourage you to take careful note of our collaborative efforts, unifying culture, scientific excellence and impact on the patient experience.
Our Community
We would not be successful in achieving our goals each year without the dedicated support of our community. Our patients, our volunteers and our donors, along with many others, allow us to provide the care and gain the scientific insights needed each year as we gain ground on cancer and other diseases.
Pitching in and playing a pivotal role
Fred Hutch volunteers devote countless hours to support patients and families.
Fred Hutch Science Education Partnership receives $1.35M grant
The award will support new programming for students and teachers on health inequities.
10 Washington groups take on cancer health disparities through grants
Community Grants Program funds projects statewide to improve cancer outcomes and build organizational capacity.
How a Black woman is coping with an ‘old white man’s disease’
Bladder cancer patient manages the stress of a disease where recurrence is common.
Our People
We welcomed amazing new folks to our team last year, from established, world-renowned experts to clinical providers and researchers just beginning their careers. We’re growing and evolving our teams to continue to make discoveries that expand the boundaries of scientific knowledge and to spearhead the development of new treatments and care standards that meet patients’ shifting needs.
Finding a calling in the midst of chemo
Fred Hutch mammographer discovers new career path during own cancer treatment.
Proton Therapy welcomes new medical director, dosimetrist
Meet Medical Director Dr. Annemarie Shepherd and Dosimetrist Blake Webb and learn what the patient access team does.
Angela Broughton honored with T. Evans Wyckoff Award at Fred Hutch
Pharmacy billing coordinator praised for her enthusiastic and dedicated patient support.
Curiosity, connection and C. elegans
How a Fred Hutch worm study gives hope to families affected by an extremely rare genetic disorder.
Giving back to her community is a way of life — and her job
Casey Costello manages Fred Hutch’s fleet of volunteers.
For Fred Hutch biostatisticians, numbers are no game
Meticulous work at the SWOG Statistics and Data Management Center, housed at Fred Hutch, may alter care for bladder cancer and lymphoma.
People by the Numbers
Data from our 2024 fiscal year ended June 30.
6,100+
350+
Facilities and Campus Update
The acquisition of more than 300,000 square feet devoted to labs and flexible spaces in September addresses the expanding need for space as we advance our research. We renovated office space to create new labs that can quickly accommodate research teams that will be part of our growing Stuart and Molly Sloan Precision Oncology Institute. One of our two patient lodging facilities gained a new name — the Behnke Family House — in recognition of the Behnkes’ extraordinary generosity to our organization. We also added new clinical facilities, including a state-of-the-art skin cancer screening device and a new mammogram van. Philanthropic support, including our Anniversary Challenge, is instrumental to our ability to create and optimize more space for our science.
Fred Hutch expands its research capacity in South Lake Union
Three new buildings will boost recruitment and strengthen science.
Mammogram vans remove barriers that people face accessing breast cancer screening
Fred Hutch focuses on improving screening in under-resourced communities.
Financial and Operational Update
We posted solid financial results in clinical and research operations.
Financial Summary
This financial data is for our fiscal year 2024 (July 1, 2023–June 30, 2024). Review our complete financial data and impact reporting.
All figures are in thousands.
Operating Revenues
Fiscal Year
Total: $2,064,034
Patient Services
$1,301,802 (63.1%)
Contracts and Government Grants
$516,304 (25.0%)
Gifts and Philanthropic Grants*
$145,774 (7.1%)
Investment Income
$34,241 (1.6%)
Other Income
$65,940 (3.2%)
Sources of
Philanthropic
Contributions
Gifts from Individuals
59%
Philanthropic Grants
21%
Planned Gifts
11%
Fundraising and Community Events
5%
Corporate Gifts
4%
Operating Expenses
Fiscal Year
Total: $2,102,011
Program Services, Clinical
$1,112,183 (52.9%)
Program Services and Research
$755,730 (36.0%)
Management and General
$206,790 (9.8%)
Fundraising
$27,308 (1.3%)
*Reflects funds expended, per GAAP standards.
Content direction by David Patton. Layout and Design by Regina Grant. Text by Fred Hutch News staff. Photography and videography by Robert Hood, Stefan Muehleis, Connor O'Shaughnessy, Rachelle Pierce and Camila Matamala-Ost.
Questions? Contact communications@fredhutch.org.